Switch theme
Sign up to access all valuation multiples
H&R GmbH & Co KGaA is a manufacturer of chemical-pharmaceutical specialty products. The company organizes its operating activities into two business divisions: Chemical-Pharmaceutical Raw Materials and Plastics. It also has three business segments: ChemPharm Refining, ChemPharm Sales, and Plastics. The ChemPharm Refining segment produces specialty products from crude oil in the two domestic refineries (Hamburg-Neuhof and Salzbergen). Its ChemPharm Sales segment encompasses the production sites abroad as well as international sales activities. The company's Plastics segment manufactures high-precision plastic parts along with the associated tools and molds. The company derives a majority of its revenue from the ChemPharm Refining segment. Geographically, it derives key revenue from Germany.
1919
1.7K+
LTM Revenue $1.5B
LTM EBITDA $103M
$334M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
H&R GmbH & Co has a last 12-month revenue (LTM) of $1.5B and a last 12-month EBITDA of $103M.
In the most recent fiscal year, H&R GmbH & Co achieved revenue of $1.5B and an EBITDA of $103M.
H&R GmbH & Co expects next 12-month revenue of XXX and NTM EBITDA of XXX
See H&R GmbH & Co valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.5B | XXX | $1.5B | XXX | XXX | XXX |
| Gross Profit | $402M | XXX | $356M | XXX | XXX | XXX |
| Gross Margin | 26% | XXX | 24% | XXX | XXX | XXX |
| EBITDA | $103M | XXX | $103M | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| EBIT | $34.9M | XXX | $41.3M | XXX | XXX | XXX |
| EBIT Margin | 2% | XXX | 3% | XXX | XXX | XXX |
| Net Profit | $12.4M | XXX | $11.9M | XXX | XXX | XXX |
| Net Margin | 1% | XXX | 1% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $100M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, H&R GmbH & Co's stock price is EUR 5 (or $6).
H&R GmbH & Co has current market cap of EUR 185M (or $208M), and EV of EUR 297M (or $334M).
See H&R GmbH & Co trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $334M | $208M | XXX | XXX | XXX | XXX | $0.33 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, H&R GmbH & Co has market cap of $208M and EV of $334M.
H&R GmbH & Co's trades at 0.2x EV/Revenue multiple, and 3.2x EV/EBITDA.
Equity research analysts estimate H&R GmbH & Co's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
H&R GmbH & Co has a P/E ratio of 16.8x.
See valuation multiples for H&R GmbH & Co and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $208M | XXX | $208M | XXX | XXX | XXX |
| EV (current) | $334M | XXX | $334M | XXX | XXX | XXX |
| EV/Revenue | 0.2x | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | 3.2x | XXX | 3.2x | XXX | XXX | XXX |
| EV/EBIT | 9.6x | XXX | 8.1x | XXX | XXX | XXX |
| EV/Gross Profit | 0.8x | XXX | n/a | XXX | XXX | XXX |
| P/E | 16.8x | XXX | 17.4x | XXX | XXX | XXX |
| EV/FCF | 14.7x | XXX | 19.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialH&R GmbH & Co's last 12 month revenue growth is 4%
H&R GmbH & Co's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.2M for the same period.
H&R GmbH & Co's rule of 40 is 10% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
H&R GmbH & Co's rule of X is 16% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for H&R GmbH & Co and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 4% | XXX | 4% | XXX | XXX | XXX |
| EBITDA Margin | 7% | XXX | 7% | XXX | XXX | XXX |
| EBITDA Growth | 0% | XXX | -3% | XXX | XXX | XXX |
| Rule of 40 | 10% | XXX | 10% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 16% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 2% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 21% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Borouge | XXX | XXX | XXX | XXX | XXX | XXX |
| Fertiglobe | XXX | XXX | XXX | XXX | XXX | XXX |
| Akzo Nobel | XXX | XXX | XXX | XXX | XXX | XXX |
| Avantium | XXX | XXX | XXX | XXX | XXX | XXX |
| DSM Firmenich | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
H&R GmbH & Co acquired XXX companies to date.
Last acquisition by H&R GmbH & Co was XXXXXXXX, XXXXX XXXXX XXXXXX . H&R GmbH & Co acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was H&R GmbH & Co founded? | H&R GmbH & Co was founded in 1919. |
| Where is H&R GmbH & Co headquartered? | H&R GmbH & Co is headquartered in Germany. |
| How many employees does H&R GmbH & Co have? | As of today, H&R GmbH & Co has 1.7K+ employees. |
| Is H&R GmbH & Co publicy listed? | Yes, H&R GmbH & Co is a public company listed on ETR. |
| What is the stock symbol of H&R GmbH & Co? | H&R GmbH & Co trades under 2HRA ticker. |
| When did H&R GmbH & Co go public? | H&R GmbH & Co went public in 1953. |
| Who are competitors of H&R GmbH & Co? | Similar companies to H&R GmbH & Co include e.g. Borouge, Fertiglobe, Akzo Nobel, Avantium. |
| What is the current market cap of H&R GmbH & Co? | H&R GmbH & Co's current market cap is $208M |
| What is the current revenue of H&R GmbH & Co? | H&R GmbH & Co's last 12 months revenue is $1.5B. |
| What is the current revenue growth of H&R GmbH & Co? | H&R GmbH & Co revenue growth (NTM/LTM) is 4%. |
| What is the current EV/Revenue multiple of H&R GmbH & Co? | Current revenue multiple of H&R GmbH & Co is 0.2x. |
| Is H&R GmbH & Co profitable? | Yes, H&R GmbH & Co is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of H&R GmbH & Co? | H&R GmbH & Co's last 12 months EBITDA is $103M. |
| What is H&R GmbH & Co's EBITDA margin? | H&R GmbH & Co's last 12 months EBITDA margin is 7%. |
| What is the current EV/EBITDA multiple of H&R GmbH & Co? | Current EBITDA multiple of H&R GmbH & Co is 3.2x. |
| What is the current FCF of H&R GmbH & Co? | H&R GmbH & Co's last 12 months FCF is $22.7M. |
| What is H&R GmbH & Co's FCF margin? | H&R GmbH & Co's last 12 months FCF margin is 1%. |
| What is the current EV/FCF multiple of H&R GmbH & Co? | Current FCF multiple of H&R GmbH & Co is 14.7x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
